Safety and Preliminary Efficacy Trial of BNT142 in Patients with CLDN6-positive Solid Tumors

Recruiting

Phase 1

Phase 2

BNT142Safety and Preliminary Efficacy Trial of BNT142 in Patients with CLDN6-positive Solid Tumors

Sponsor:

BioNTech SE

Code:

NCT05262530

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BNT142

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-22. This information was provided to ClinicalTrials.gov by BioNTech SE on 2025-01-31.